Pulmonary valve balloon valvuloplasty compared across three age groups of children

Shamsi Ghaffari1, Mohammed Reza Ghaffari, Ali Reza Ghaffari

  • 1Department of Pediatric Cardiology, Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Insights

Percutaneous pulmonary valvuloplasty is an effective treatment for moderate pulmonary stenosis in children. While complications like failure and mortality occurred, they were not significantly higher in younger children, suggesting safety across pediatric age groups.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Congenital Heart Disease

Background:

  • Pulmonary stenosis is a common congenital heart defect.
  • Percutaneous balloon valvuloplasty is a primary treatment modality.
  • Understanding outcomes across pediatric age groups is crucial.

Purpose of the Study:

  • To evaluate the characteristics and outcomes of percutaneous pulmonary valvuloplasty.
  • To compare treatment results among three pediatric age cohorts.
  • To identify factors influencing procedural success and complications.

Main Methods:

  • Retrospective analysis of pediatric patients (<15 years) undergoing pulmonary valve balloon valvuloplasty.
  • Data collected from 2005-2009 at Madani Heart Center.
  • Statistical analysis using IBM SPSS software.

Main Results:

  • Mean patient age was 55.5 ± 47.4 months.
  • Two-thirds of patients had moderate pulmonary stenosis.
  • Procedural failure occurred in nearly 20% of patients, with 2 mortalities.
  • Mild pulmonary valve insufficiency was a frequent finding.
  • Complication rates were descriptively lower in older children (>5 years) but not statistically significant.

Conclusions:

  • Percutaneous pulmonary valvuloplasty is a viable treatment for pediatric pulmonary stenosis.
  • The procedure demonstrates acceptable safety and efficacy across different childhood age groups.
  • Further research may elucidate statistically significant differences in outcomes based on age.